CH602785A5 - - Google Patents

Info

Publication number
CH602785A5
CH602785A5 CH343674A CH343674A CH602785A5 CH 602785 A5 CH602785 A5 CH 602785A5 CH 343674 A CH343674 A CH 343674A CH 343674 A CH343674 A CH 343674A CH 602785 A5 CH602785 A5 CH 602785A5
Authority
CH
Switzerland
Application number
CH343674A
Inventor
Joseph Theodore Witkowski
Roland Kenith Robins
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US340332A external-priority patent/US3927216A/en
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of CH602785A5 publication Critical patent/CH602785A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
CH343674A 1973-03-12 1974-03-12 CH602785A5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US340332A US3927216A (en) 1971-06-01 1973-03-12 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections

Publications (1)

Publication Number Publication Date
CH602785A5 true CH602785A5 (es) 1978-08-15

Family

ID=23332899

Family Applications (1)

Application Number Title Priority Date Filing Date
CH343674A CH602785A5 (es) 1973-03-12 1974-03-12

Country Status (15)

Country Link
JP (2) JPS5836960B2 (es)
AR (1) AR205339A1 (es)
BE (2) BE812191A (es)
CH (1) CH602785A5 (es)
DE (1) DE2411823A1 (es)
ES (1) ES424201A1 (es)
FR (2) FR2221138B1 (es)
GB (1) GB1427304A (es)
IE (1) IE38987B1 (es)
IL (2) IL44394A0 (es)
LU (1) LU69626A1 (es)
NL (1) NL7403289A (es)
NO (1) NO138376C (es)
PH (1) PH12043A (es)
ZA (1) ZA741610B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2940654A1 (de) * 1979-10-06 1981-04-16 Bayer Ag, 5090 Leverkusen Dimeres keten der 1,2,,-triazol-3-carbonsaeure
EP0034481B1 (en) * 1980-02-14 1984-05-30 Grigg, Ronald Ernest 2-methyl-5-thiazole-methylamine and carboxamide derivatives
FI70425C (fi) * 1980-04-23 1986-09-19 Wellcome Found Foerfarande foer framstaellning av 4-substituerade 1-beta-ribofuranosyl-1h-imidazo/4,5-c/pyridiner
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
BE902199A (fr) * 1984-10-29 1985-07-31 Vira Tek Inc Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.
JPS62165096A (ja) * 1986-01-14 1987-07-21 Hitachi Ltd 給油装置
JPWO2009028575A1 (ja) 2007-08-27 2010-12-02 国立大学法人名古屋大学 血液凝固第vii因子プロモーターの活性化剤及びその利用
WO2009028573A1 (ja) 2007-08-27 2009-03-05 National University Corporation Nagoya University 血液凝固障害におけるリバビリンの利用

Also Published As

Publication number Publication date
ES424201A1 (es) 1976-05-01
FR2289520B1 (es) 1978-05-12
LU69626A1 (es) 1974-08-06
BE812191A (fr) 1974-07-01
JPS5836960B2 (ja) 1983-08-12
FR2289520A1 (fr) 1976-05-28
GB1427304A (en) 1976-03-10
FR2221138B1 (es) 1978-07-28
ZA741610B (en) 1975-02-26
NL7403289A (es) 1974-09-16
AU6670874A (en) 1975-09-18
NO138376C (no) 1978-08-23
PH12043A (en) 1978-10-18
JPS5029720A (es) 1975-03-25
FR2221138A1 (es) 1974-10-11
IE38987L (en) 1974-09-12
NO138376B (no) 1978-05-16
IL44394A0 (en) 1974-06-30
AR205339A1 (es) 1976-04-30
JPS58219115A (ja) 1983-12-20
NO740841L (no) 1974-09-13
DE2411823A1 (de) 1974-09-26
IL52848A0 (en) 1977-10-31
BE903675Q (fr) 1986-05-20
JPS5915886B2 (ja) 1984-04-12
IE38987B1 (en) 1978-07-05

Similar Documents

Publication Publication Date Title
AR201758A1 (es)
AU465372B2 (es)
AR201235Q (es)
AR201231Q (es)
AU474593B2 (es)
AU474511B2 (es)
AU474838B2 (es)
AU465453B2 (es)
AU471343B2 (es)
AU465434B2 (es)
AU450229B2 (es)
FR2221138B1 (es)
AR201229Q (es)
AU466283B2 (es)
AU472848B2 (es)
AR199451A1 (es)
AU447540B2 (es)
AR210729A1 (es)
AR195311A1 (es)
AR201432A1 (es)
AU471461B2 (es)
AR197627A1 (es)
AR195948A1 (es)
AU461342B2 (es)
AR200885A1 (es)

Legal Events

Date Code Title Description
PL Patent ceased